Inventor
FYFE MATTHEW COLIN THOR
GB56 patents
⚠️ This page may combine multiple inventors who share the name “FYFE MATTHEW COLIN THOR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RESPIVERT LTD
12 patentsUS8927563B2Jan 6, 2015
Kinase inhibitor
RESPIVERT LTD39 citations98
US9499486B2Nov 22, 2016
Kinase inhibitor
RESPIVERT LTD14 citations92
US9481648B2Nov 1, 2016
Kinase inhibitors
RESPIVERT LTD22 citations90
US9822076B2Nov 21, 2017
Kinase inhibitor
RESPIVERT LTD3 citations84
US10125100B2Nov 13, 2018
Kinase inhibitors
RESPIVERT LTD6 citations83
US9751837B2Sep 5, 2017
Kinase inhibitors
RESPIVERT LTD6 citations83
US9890185B2Feb 13, 2018
Urea derivatives useful as kinase inhibitors
RESPIVERT LTD8 citations82
US9701670B2Jul 11, 2017
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD10 citations80
US9771353B2Sep 26, 2017
Kinase inhibitors based upon N-alkyl pyrazoles
RESPIVERT LTD3 citations73
US10072034B2Sep 11, 2018
Kinase inhibitors
RESPIVERT LTD3 citations72
US9796742B2Oct 24, 2017
Kinase inhibitors
RESPIVERT LTD2 citations62
US9850233B2Dec 26, 2017
Kinase inhibitors
RESPIVERT LTD0 citations52
ORYZON GENOMICS SA
12 patentsUS9149447B2Oct 6, 2015
Lysine specific demethylase-1 inhibitors and their use
ORYZON GENOMICS SA20 citations90
US9670136B2Jun 6, 2017
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
ORYZON GENOMICS SA8 citations83
US9708309B2Jul 18, 2017
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
ORYZON GENOMICS SA7 citations82
US9676701B2Jun 13, 2017
Cyclopropylamine derivatives useful as LSD1 inhibitors
ORYZON GENOMICS SA7 citations82
US9487512B2Nov 8, 2016
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
ORYZON GENOMICS SA8 citations82
US9469597B2Oct 18, 2016
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
ORYZON GENOMICS SA8 citations81
US10329256B2Jun 25, 2019
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
ORYZON GENOMICS SA1 citations72
US10214477B2Feb 26, 2019
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
ORYZON GENOMICS SA1 citations72
US9944601B2Apr 17, 2018
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
ORYZON GENOMICS SA4 citations72
US10233178B2Mar 19, 2019
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
ORYZON GENOMICS SA1 citations71
US10202330B2Feb 12, 2019
Lysine specific demethylase-1 inhibitors and their use
ORYZON GENOMICS SA1 citations71
US9908859B2Mar 6, 2018
Lysine demethylase inhibitors for myeloproliferative disorders
ORYZON GENOMICS SA6 citations68
TOPIVERT PHARMA LTD
7 patentsUS10392346B2Aug 27, 2019
Kinase inhibitors
TOPIVERT PHARMA LTD2 citations71
US10435361B2Oct 8, 2019
Kinase inhibitors
TOPIVERT PHARMA LTD3 citations69
US10882859B2Jan 5, 2021
Kinase inhibitors
TOPIVERT PHARMA LTD0 citations62
US10301288B2May 28, 2019
Kinase inhibitors
TOPIVERT PHARMA LTD1 citations62
US10556901B2Feb 11, 2020
4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as Janus kinase inhibitors
TOPIVERT PHARMA LTD0 citations51
US10442828B2Oct 15, 2019
Kinase inhibitors
TOPIVERT PHARMA LTD0 citations51
US10851097B2Dec 1, 2020
4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as janus kinase inhibitors
TOPIVERT PHARMA LTD0 citations41
PROSIDION LTD
4 patentsUS7262196B2Aug 28, 2007
Tri(cyclo) substituted amide glucokinase activator compounds
PROSIDION LTD11 citations81
US7214681B2May 8, 2007
Tri(cyclo) substituted amide compounds
PROSIDION LTD7 citations71
US7745491B2Jun 29, 2010
Substituted phenylacetamides and their use as glucokinase activators
PROSIDION LTD0 citations50
US7582632B2Sep 1, 2009
Tri(cyclo) substituted amide compounds
PROSIDION LTD0 citations49
FYFE MATTHEW COLIN THOR
3 patentsUS9006449B2Apr 14, 2015
Cyclopropylamine derivatives useful as LSD1 inhibitors
FYFE MATTHEW COLIN THOR19 citations90
US8207147B2Jun 26, 2012
Heterocyclic derivatives as GPCR receptor agonists
FYFE MATTHEW COLIN THOR10 citations80
US8193359B2Jun 5, 2012
G-protein coupled receptor agonists
FYFE MATTHEW COLIN THOR2 citations55
ORTEGA MUÑOZ ALBERTO
3 patentsUS9181198B2Nov 10, 2015
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
ORTEGA MUÑOZ ALBERTO17 citations87
US8946296B2Feb 3, 2015
Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
ORTEGA MUÑOZ ALBERTO17 citations82
US8859555B2Oct 14, 2014
Lysine Specific Demethylase-1 inhibitors and their use
ORTEGA MUÑOZ ALBERTO18 citations82
WARNER LAMBERT CO
3 patentsSITRYX THERAPEUTICS LTD
2 patentsUS12459908B2Nov 4, 2025
Alpha, beta unsaturated methacrylic esters with anti-inflammatory properties
SITRYX THERAPEUTICS LTD0 citations45
US12390437B2Aug 19, 2025
Itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune response
SITRYX THERAPEUTICS LTD0 citations43
BAKER JONATHAN ALLEMAN
1 patentORTEGA MUNOZ ALBERTO
1 patentLARIA JULIO CASTRO-PALOMINO
1 patentOXULAR ACQUISITIONS LTD
1 patentShowing the top 50 of 56 patents by PatentIndex Score.